J&J/Critikon
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson divests its Critikon patient monitoring business to investor group led by Liberty Partners and Critikon management for undisclosed terms. Going private allows Tampa, Florida-based Critikon "to focus on our strength in vital signs monitoring, specifically non-invasive blood pressure detection and blood pressure cuffs, while improving the access to vital information for caregivers," President and CEO Gordie Nye states